Mittwoch, 19.06.2013Börsentäglich über 11.000 News von 442 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

VERENIUM CORPORATION

WKN: A0X9PR  ISIN: US92340P2092  Ticker-Symbol: DVG1 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
VERENIUM CORPORATION Chart 1 Jahr
1-Woche-Intraday-Chart
VERENIUM CORPORATION 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
1,677
1,74
13:31
Aktuelle News zur VERENIUM Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
10.06.13
SAN DIEGO, June 10, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
10.06.14
SAN DIEGO, June 10, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology
28.05.18
SAN DIEGO, May 28, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium To Introduce New Enzyme Product At 2013 International Fuel Ethanol Workshop & Expo
23.05.13
SAN DIEGO, May 23, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium To Present At Two Upcoming Conferences
10.05.8
09.05.-
09.05.58
SAN DIEGO, May 9, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes,...
Mehr lesen zu:
Verenium Reports Financial Results For The First Quarter Ended March 31, 2013
02.05.17
SAN DIEGO, May 2, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance...
Mehr lesen zu:
Verenium Corporation to Announce First Quarter 2013 Financial Results
28.03.5
27.03.37
SAN DIEGO, Calif., March 27, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance...
Mehr lesen zu:
Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012
18.03.29
SAN DIEGO, March 18, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium Corporation To Announce Fourth Quarter And Year End 2012 Financial Results
14.03.44
SAN DIEGO, March 14, 2013 /PRNewswire/ -- Verenium Corporation (the "Company") (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance...
Mehr lesen zu:
Verenium Announces Preliminary Financial Results For Fiscal 2012
12.03.26
SAN DIEGO, March 12, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium To Present At The 25Th Annual Roth Conference
26.02.37
SAN DIEGO, Feb. 26, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium Appoints Holger Liepmann To Its Board Of Directors
04.02.25
SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference
04.02.31
SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium Announces Commercial Launch Of Pyrolase HT Product
30.01.44
ST. LOUIS and SAN DIEGO, Jan. 30, 2013 /PRNewswire/ --Novus International Inc., a leading manufacturer of animal nutrition and health products and Verenium Corporation (Nasdaq: VRNM), a leading industrial...
Mehr lesen zu:
Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
10.12.85
SAN DIEGO, Dec. 10, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium Announces $22.5 Million, Five-Year Secured Financing
08.11.34
SAN DIEGO, Nov. 8, 2012 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance...
Mehr lesen zu:
Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012
01.11.20
SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes...
Mehr lesen zu:
Verenium Corporation To Announce Third Quarter 2012 Financial Results
Seite: 1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
Aufklappen
Schliessen